Pharmaceutical preparations company · NV · FY ends Dec · Revenue $1M · -3842.32% margin · -$17M FCF
The business is unprofitable at the operating level (-3842.32% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 95.3% YoY with margins expanding 6277.7pp.
Negative free cash flow of -$17M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$1M
▲ +95.3% YoY
Net Income (TTM)
-$48M
▲ +13.0% YoY
Op. Margin
-3842.32%
▲ +6277.7pp YoY
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
-$17M
▼ -2.4% YoY
Op. Cash Flow (TTM)
-$17M
▼ -15.1% YoY
Net Debt
$13M
Cash & Equiv.
$78K
5Y CAGR: -23.3%
Continue Research